open access

Vol 82, No 10 (2011)
ARTICLES
Get Citation

Endometrioid endometrial cancer – the prognostic value of selected clinical and pathological parameters

Leszek Gottwald, Justyna Chałubińska, Małgorzata Moszyńska-Zielińska, Janusz Piekarski, Wiesław Tyliński, Jarosław Szwalski, Robert Kubiak, Grażyna Pasz-Walczak, Katarzyna Hendzel, Aleksandra Ciałkowska-Rysz
Ginekol Pol 2011;82(10).

open access

Vol 82, No 10 (2011)
ARTICLES

Abstract

Objectives: to assess the relationship between selected clinical and pathological factors and disease free survival (DFS) and overall survival (OS) in endometrioid endometrial cancer patients. Material and methods: A retrospective review of 262 patients aged 37-86 (6.0±9.0) was performed. Selected clinical and pathological data were correlated with DFS and OS. Results: Follow-up was 8-123 months (64.9±27.1). In 4 patients (1.5%) clinical progression was diagnosed during the treatment. In 43 patients (16.4%) relapse was diagnosed 2-61 months (23.9±15.7) after commencing treatment. DFS and OS were 82.1% and 81.3% respectively. In univariate analysis worse DFS was related to older patients (p=0.007) and non-radical surgery (p<0.001). In multivariate analysis worse DFS was related to older patients (HR=1.058; 95%CI=1.024-1.093; p<0.001), younger at menopause (HR=0.910; 95%CI=0.851-0.973;p=0.006), with higher staging (HR=2.639; 95%CI=1.968-3.539; p<0.001) operated non-radically (HR=0.220;95%CI=0.096-0.504; p<0.001). In univariate analysis worse OS was connected with older patients (p=0.018), diabetes type II (p=0.019) and non-radical surgery (p<0.001). In multivariate analysis worse OS was related to younger age at menopause (HR=0.932; 95%CI=0.873-0.996; p=0.039), diabetes type II (HR=2.372; 95%CI=1.260-4.466; p=0.008), higher staging (HR=2.053; 95%CI=1.482-2.845; p<0.001), and non-radical surgery (HR=0.240;95%CI=0.091-0.636; p=0.004). Conclusions: Relapsed endometrial cancer developed in 90.7% during four years after commencing treatment. In 79.1% of these patients distant metastases were present. Most significant prognostic factors were radicality of surgery, age of patients and staging. The presence of diabetes type II and early menopause were connected with worse prognosis.

Abstract

Objectives: to assess the relationship between selected clinical and pathological factors and disease free survival (DFS) and overall survival (OS) in endometrioid endometrial cancer patients. Material and methods: A retrospective review of 262 patients aged 37-86 (6.0±9.0) was performed. Selected clinical and pathological data were correlated with DFS and OS. Results: Follow-up was 8-123 months (64.9±27.1). In 4 patients (1.5%) clinical progression was diagnosed during the treatment. In 43 patients (16.4%) relapse was diagnosed 2-61 months (23.9±15.7) after commencing treatment. DFS and OS were 82.1% and 81.3% respectively. In univariate analysis worse DFS was related to older patients (p=0.007) and non-radical surgery (p<0.001). In multivariate analysis worse DFS was related to older patients (HR=1.058; 95%CI=1.024-1.093; p<0.001), younger at menopause (HR=0.910; 95%CI=0.851-0.973;p=0.006), with higher staging (HR=2.639; 95%CI=1.968-3.539; p<0.001) operated non-radically (HR=0.220;95%CI=0.096-0.504; p<0.001). In univariate analysis worse OS was connected with older patients (p=0.018), diabetes type II (p=0.019) and non-radical surgery (p<0.001). In multivariate analysis worse OS was related to younger age at menopause (HR=0.932; 95%CI=0.873-0.996; p=0.039), diabetes type II (HR=2.372; 95%CI=1.260-4.466; p=0.008), higher staging (HR=2.053; 95%CI=1.482-2.845; p<0.001), and non-radical surgery (HR=0.240;95%CI=0.091-0.636; p=0.004). Conclusions: Relapsed endometrial cancer developed in 90.7% during four years after commencing treatment. In 79.1% of these patients distant metastases were present. Most significant prognostic factors were radicality of surgery, age of patients and staging. The presence of diabetes type II and early menopause were connected with worse prognosis.
Get Citation

Keywords

endometrial adenocarcinoma, endometrioid carcinoma, prognostic factors, overall survival

About this article
Title

Endometrioid endometrial cancer – the prognostic value of selected clinical and pathological parameters

Journal

Ginekologia Polska

Issue

Vol 82, No 10 (2011)

Bibliographic record

Ginekol Pol 2011;82(10).

Keywords

endometrial adenocarcinoma
endometrioid carcinoma
prognostic factors
overall survival

Authors

Leszek Gottwald
Justyna Chałubińska
Małgorzata Moszyńska-Zielińska
Janusz Piekarski
Wiesław Tyliński
Jarosław Szwalski
Robert Kubiak
Grażyna Pasz-Walczak
Katarzyna Hendzel
Aleksandra Ciałkowska-Rysz

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl